Kolexia
Le Clech Lenaig
Hématologie
Centre hospitalier de Cornouaille
Quimper, France
62 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Syndromes myéloprolifératifs Syndromes myélodysplasiques Leucémies Thrombocytose Leucémie myélomonocytaire chronique Thrombose Thrombocytémie essentielle Polyglobulie primitive essentielle Polyglobulie

Industries

Janssen
7 collaboration(s)
Dernière en 2023
Amgen
5 collaboration(s)
Dernière en 2023
Novartis
5 collaboration(s)
Dernière en 2023
AstraZeneca
5 collaboration(s)
Dernière en 2023

Dernières activités

CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM.
American journal of hematology   25 février 2024
Identification des mutations somatiques et analyse des mécanismes immunologiques au cours des manifestations auto-immunes et/ou inflammatoires associées à la leucémie myélomonocytaire chronique
87e CONGRÈS FRANÇAIS DE MÉDECINE INTERNE   01 décembre 2023
Autoimmune Cytopenia Associated with Indolent B-Cell Clones: A Large Multicentric Cohort Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
Efficacy and Safety of Luspatercept +/- Erythropoiesis-Stimulating Agent (ESA) in Patients with Myelodysplastic Syndromes with Ring Sideroblasts (MDS-RS): A French Multicenter Prospective Real-Life Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
HEMVACO: Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology Patients
Essai Clinique (Centre hospitalier de Cornouaille)   29 août 2023
Thrombosis with Non-Proliferative Complete Blood Count Indicative of Underlying Myeloproliferative Neoplasm, Sythrom, a Study on Behalf of the FIM Group
Annual Meeting Abstracts 2022   15 novembre 2022
Histological and genetic characterization and follow-up of 130 patients with chronic triple-negative thrombocytosis.
Haematologica   01 novembre 2022
Benefice and pitfall of direct oral anticoagulants in very high-risk myeloproliferative neoplasms.
Thrombosis research   06 juin 2022
The humoral response of mRNA COVID-19 vaccine in hematological diseases: The HEMVACO study.
Infectious diseases now   03 juin 2022
Achievement of rapid complete remission in an 87-year-old female patient with azacytidine-venetoclax for blastic plasmacytoid dendritic cell neoplasm.
Annals of hematology   06 mars 2022